New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Progyny, Inc.
PGNY
Shape
US Flag

NASDAQ

1B

Medical - Healthcare Information Services

Next Earning date - 05 Nov 2024

1B

Medical - Healthcare Information Services

Next Earning date - 05 Nov 2024

15.45USD
Shape-0.10 ( -0.64%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-26%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

63%

Quote Panel

Shape
Updated October 26, 2024
1W -5.50 % 1M -8.04 % 3M -46.76 % 1Y -49.33 %

Key Metrics

Shape
  • Market Cap

    1.39B


  • Shares Outstanding

    90.28M


  • Share in Float

    76.48M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    15.45


  • Average Volume

    2.28M


  • Beta

    1.429


  • Range

    13.93-42.08


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.progyny.com


  • Sector

    Healthcare


Fundamentals

Shape

11.88x

P/E Ratio

1.23x

P/S Ratio

3.18x

P/B Ratio

0.0

Debt/Equity

5.5%

Net Margin

$0.6

EPS

How PGNY compares to sector?

P/E Ratio

Relative Strength

Shape

PGNY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape300%

2025-Revenue

$0.70

Shape291%

2025-EPS

$78M

Shape262%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

JMP Securities

downgrade

Previous: Underperform

2024-09-19

Now: Market Perform

BTIG

downgrade

Previous: Buy

2024-08-07

Now: Neutral

Canaccord Genuity

downgrade

Previous: Not converted

2024-08-07

Now: Reduce

JMP Securities

initialise

Previous: Not converted

2024-07-16

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-24%

0.13
vs 0.17

Q4.22

arrow
arrow

-80%

0.03
vs 0.15

Q1.23

arrow
arrow

+260%

0.18
vs 0.05

Q2.23

arrow
arrow

+67%

0.15
vs 0.09

Q3.23

arrow
arrow

+23%

0.16
vs 0.13

Q4.23

arrow
arrow

+967%

0.32
vs 0.03

Q1.24

arrow
arrow

+117%

0.39
vs 0.18

Q2.24

arrow
arrow

+187%

0.43
vs 0.15

Q3.24

arrow
arrow

-11%

0.14
vs 0.16

Q4.24

arrow
arrow

-55%

0.14
vs 0.32

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+68%

205.4M  vs 122.3M

Q4.22

arrow
arrow

+68%

214.3M  vs 127.6M

Q1.23

arrow
arrow

+50%

258.4M  vs 172.2M

Q2.23

arrow
arrow

+43%

279.4M  vs 195M

Q3.23

arrow
arrow

+37%

280.9M  vs 205.4M

Q4.23

arrow
arrow

+26%

269.9M  vs 214.3M

Q1.24

arrow
arrow

+8%

278.1M  vs 258.4M

Q2.24

arrow
arrow

+9%

304.1M  vs 279.4M

Q3.24

arrow
arrow

+6%

296.9M  vs 280.9M

Q4.24

arrow
arrow

+8%

292.7M  vs 269.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.03

Q4.22

arrow
arrow

+1%

0.01
vs 0.04

Q1.23

arrow
arrow

+4%

0.04
vs 0.01

Q2.23

arrow
arrow

+3%

0.03
vs 0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q4.23

arrow
arrow

+2%

0.02
vs 0.03

Q1.24

arrow
arrow

+3%

0.03
vs 0.02

Q2.24

arrow
arrow

+4%

0.04
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

285

285
vs 250

14%

Q4.22

arrow
arrow

276

276
vs 285

-3%

Q1.23

arrow
arrow

285

285
vs 276

3%

Q2.23

arrow
arrow

316

316
vs 285

11%

Q3.23

arrow
arrow

332

332
vs 316

5%

Q4.23

arrow
arrow

327

327
vs 332

-2%

Q1.24

arrow
arrow

335

335
vs 327

2%

Q2.24

arrow
arrow

325

325
vs 335

-3%

Earnings Growth

Latest News